Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
1.
J Gastrointest Cancer ; 54(2): 651-661, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35881277

RESUMEN

PURPOSE: Molecular analysis of peritoneal fluid in staging laparoscopy of gastric cancer is performed to improve the detection of free intraperitoneal tumor cells. Nevertheless, its significance is controversial, especially in patients with negative cytology but positive molecular analysis. The aim of this study was to analyze the sensitivity of molecular analysis and its prognostic value. METHODS: A retrospective analysis from April 2011 to October 2019 was performed. Cytology (Cyt) and molecular analysis were analyzed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) of the carcinoembryonic antigen (CEA) and cytokeratin 20 (CK20) tumor makers. RESULTS: During the study period, 138 staging laparoscopies were performed. Macroscopic carcinomatosis was found in 12.3%. Of the remaining 87.7%, 9.9% were Cyt + and 11.6% were Cyt- RT-PCR + . Of the latter, 9 responded to chemotherapy and underwent radical surgery. The sensitivity of cytology and molecular analysis was 0.70 and 0.76, respectively (p = 0.67). The 2-year overall survival (OS) of Cyt- RT-PCR + vs. Cyt + was similar (p = 0.1). The 2-year OS of Cyt-RT-PCR + subgroup who underwent radical surgery vs. Cyt-RT-PCR- patients was similar (p = 0.69), but disease-free survival was shorter in the first group (p = 0.005). CONCLUSION: Our results show that the sensitivity of molecular analysis is similar to that of cytology. The prognostic value of positive molecular analysis was similar to positive cytology in terms of 2-year overall survival, except in the subgroup of operated patients in whom the overall survival was similar to that of those with a negative molecular analysis, albeit with a shorter disease-free survival.


Asunto(s)
Laparoscopía , Neoplasias Gástricas , Humanos , Líquido Ascítico/química , Líquido Ascítico/patología , Neoplasias Gástricas/genética , Neoplasias Gástricas/cirugía , Estudios Retrospectivos , Terapia Neoadyuvante , Antígeno Carcinoembrionario , Pronóstico , Estadificación de Neoplasias , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
3.
Med Mal Infect ; 50(8): 689-695, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31759689

RESUMEN

OBJECTIVES: We aimed to assess the incidence of respiratory tract infections in military settings between 2006 and 2015. PATIENTS AND METHODS: We performed a retrospective epidemiological study of the entire military population from 2006 to 2015. Comprehensive data was collected from all medical centers, operational medical units, naval services, and army training hospitals and provided by the epidemiological surveillance of the armies. RESULTS: The annual average population of the study was 331,394 soldiers. For acute respiratory tract infections (2006-2015), 22,818 cases were reported in metropolitan France, 3,211 cases in French overseas territories, 1,595 cases in the French Navy, and 1,318 cases in external military operations for a total of 28,942 cases. For influenza (2006-2013), 934 cases were reported in metropolitan France, 101 cases in French overseas territories, and 23 cases in external operations, for a total of 1,058 cases. The mean incidence rate of acute respiratory tract infections expressed as case number per 1,000 person-years (PY) was 8.7 PY (95% CI [8.6-8.8]) with an exceptional increased incidence rate in 2009 (25.9 PY, 95% CI [25.4-26.4]). The mean incidence rate of influenza was 0.35 PY (95% CI [0.33-0.37]) with a peak incidence rate of 1.9 PY in 2009. CONCLUSION: Acute respiratory tract infections are at the forefront of infectious episodes in the French armies. Although not necessarily severe, current prevention measures are not enough to reduce the incidence threshold of these infections and need to be improved.


Asunto(s)
Enfermedades Transmisibles , Gripe Humana , Personal Militar , Humanos , Incidencia , Gripe Humana/epidemiología , Estudios Retrospectivos
4.
Eur Arch Otorhinolaryngol ; 276(11): 3095-3104, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31363901

RESUMEN

PURPOSE: Intense bleeding of the surgical field is a potential factor influencing success of functional endoscopic sinus surgery (FESS). Hypotensive anesthesia with α2 intravenous agonists reduces intraoperative bleeding, but which is the best agent is unknown. The main objective of this trial was to compare the current standard adjuvant drug for hypotensive anesthesia, clonidine, with the recently available alternative dexmedetomidine. METHODS: A randomized clinical trial compared the efficacy of clonidine and dexmedetomidine during FESS. Treatment was open label for the anesthesiologist and operating surgeon, but blind for an external evaluator who evaluated video-recorded surgeries. A Boezaart scale was assessed every 30 min during FESS until surgery completion. Main end-point was the proportion of patients with mean Boezaart scores > 2 (heavy bleeding) by external blinded evaluator. Secondary end-points included other bleeding parameters, surgery duration, hemodynamic measures and surgical complications. RESULTS: 94 patients were randomized. There were no significant differences in the proportion of patients with mean Boezaart scores > 2 in clonidine (42.6%) and dexmedetomidine (42.6%). Consistently, no differences were observed in secondary variables of bleeding, duration or complications. Small differences in mean heart rate were observed that might reflect different pharmacological profiles of the products, but are of uncertain clinical relevance. CONCLUSIONS: No significant differences were observed between clonidine and dexmedetomidine when used as anesthetic adjuvants in the reduction of surgical bleeding in FESS. A longer experience with clonidine and its lower costs suggest it may be a preferable option as an adjuvant for hypotensive anesthesia.


Asunto(s)
Anestesia/métodos , Pérdida de Sangre Quirúrgica/prevención & control , Clonidina , Dexmedetomidina , Endoscopía , Senos Paranasales/cirugía , Agonistas de Receptores Adrenérgicos alfa 2/administración & dosificación , Agonistas de Receptores Adrenérgicos alfa 2/efectos adversos , Enfermedad Crónica , Clonidina/administración & dosificación , Clonidina/efectos adversos , Dexmedetomidina/administración & dosificación , Dexmedetomidina/efectos adversos , Endoscopía/efectos adversos , Endoscopía/métodos , Femenino , Hemodinámica/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Pólipos Nasales/cirugía , Tempo Operativo , Rinitis/cirugía , Sinusitis/cirugía , Resultado del Tratamiento
5.
Clin Exp Allergy ; 41(5): 649-56, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21105919

RESUMEN

BACKGROUND: It is difficult to find a causal relationship between exposure to Alternaria spores and the development of asthma symptoms in sensitized individuals due to the complexity of clinical situations in which positive diagnostic tests are often found. OBJECTIVE: To analyse the diagnostic efficiency of skin testing (ST) and serum-specific IgE to Alternaria, based on the results of a bronchial specific challenge with Alternaria extracts. METHODS: Seventy-four asthmatic patients sensitized to Alternaria underwent a specific bronchial challenge with this mould. Skin-testing weal sizes, serum-specific IgE values (CAP-system) and bronchial challenge results were analysed by receiver operating characteristics curves (ROC curves) and logistic regression. The sensitivity, specificity, positive and negative predictive values were calculated for different cut-off points. RESULTS: Bronchial challenges to Alternaria elicited a positive result in 45 patients (61%). Skin prick testing almost perfectly predicted the outcome of bronchoprovocation tests (area under the ROC curve of 0.957), whereas intradermal skin testing had moderate efficacy. A negative result for skin prick test (SPT) showed a 4% probability of a positive bronchial challenge in the logistic regression analysis. However, weals around 5.5 mm in diameter had 90% probability of a positive challenge. Quantification of serum-specific IgE correctly classified 86% of the cases. In the logistic regression analysis, a CAP value 16 kU(A)/L predicted a positive bronchial challenge result with 99% accuracy, whereas for a CAP value <0.35 kU(A)/L, this probability was 33%. CONCLUSIONS AND CLINICAL RELEVANCE: Most asthmatic patients with positive SPT results to Alternaria would have a positive bronchial challenge. As atmospheric mould levels may vary significantly with the weather conditions, sensitized patients should be instructed on the risk situations, environmental control measures and the importance of correct medication compliance. Immunotherapy with Alternaria could also be taken into account as a valid therapeutic option.


Asunto(s)
Alternaria/inmunología , Asma/inmunología , Pruebas de Provocación Bronquial/métodos , Inmunoglobulina E/inmunología , Pruebas Cutáneas/métodos , Adolescente , Asma/microbiología , Femenino , Humanos , Inmunoglobulina E/sangre , Masculino , Valor Predictivo de las Pruebas , Curva ROC , Análisis de Regresión , Estudios Retrospectivos , Sensibilidad y Especificidad , Adulto Joven
6.
Allergy ; 63(1): 112-5, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18053020

RESUMEN

BACKGROUND AND AIMS: Aspirin, a cyclo-oxygenase (COX)-1 and COX-2 inhibitor, is the antiplatelet drug of choice to prevent serious vascular events. Adverse reactions to aspirin are frequent particularly among patients with asthma, chronic rhinosinusitis and nasal polyps. COX-1 inhibitors but not COX-2 inhibitors precipitate asthma attacks. Triflusal is a preferential COX-2 inhibitor antiplatelet agent that is as effective as aspirin in the prevention of serious vascular events. The aim of the study was to assess the tolerability of triflusal in patients with aspirin-exacerbated respiratory disease (AERD). METHODS: We studied 26 asthma patients [11 males, aged 52 (23-75) years] who had suffered asthma episodes triggered by one or more (23% of patients) nonsteroidal anti-inflammatory drugs. Aspirin sensitivity was confirmed by either intranasal or oral aspirin challenge. All subjects underwent a single-blind, placebo-controlled oral challenge with three doses of triflusal separated by 1 week (first cumulative dose = 225 mg; second cumulative dose = 450 mg; third cumulative dose = 900 mg). Cutaneous, respiratory, general symptoms and lung function were monitored for 4 h in the laboratory and for 24 h at home. RESULTS: No clinical reactions to triflusal were observed. There were no significant changes in lung function measurements. CONCLUSION: Our study appears to demonstrate that triflusal is a suitable alternative to aspirin as antiplatelet agent to prevent AERD.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Aspirina/efectos adversos , Asma/tratamiento farmacológico , Hipersensibilidad a las Drogas/tratamiento farmacológico , Salicilatos/administración & dosificación , Administración Oral , Adulto , Anciano , Asma/inmunología , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Hipersensibilidad a las Drogas/etiología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Probabilidad , Valores de Referencia , Pruebas de Función Respiratoria , Medición de Riesgo , Índice de Severidad de la Enfermedad , Método Simple Ciego , Resultado del Tratamiento
7.
Rev. peru. cardiol. (Lima) ; 33(3): 121-127, sept.-dic. 2007. tab, graf
Artículo en Español | LILACS, LIPECS | ID: lil-538577

RESUMEN

Objetivo: Determinar la prevalencia de Fibrilación Auricular en pacientes hospitalizados por Enfermedad Cerebrovascular. Material y Métodos: Se realizó un estudio descriptivo de corte transversal. Se revisaron las historias clínicas de pacientes con diagnóstico de Enfermedad Cerebrovascular del Hospital Nacional Cayetano Heredia y del Hospital Nacional Arzobispo Loayza desde febrero a junio del 2006, completßndose 136 casos (29 del Hospital Nacional Cayetano Heredia y 107 del Hospital Nacional Arzobispo Loayza). Resultados: Entre los 136 pacientes con Enfermedad Cerebrovascular, 116 fueron de etiología isquémica (85.3 por ciento) y 20 hemorrßgica. 75 fueron mujeres (55.1 por ciento). La prevalencia de Fibrilación Auricular encontrada fue:13,2 por ciento. La edad media de los pacientes con Fibrilación Auricular (79.72 ± 7.09) fue mayor que aquellos sin Fibrilación Auricular (65.75 ± 14.73) (p<0.01). La dilatación auricular izquierda fue el hallazgo ecocardiogrßfico mßs frecuente (92.3 por ciento) en pacientes con Fibrilación Auricular (p<0.01). Conclusiones: La Fibrilación Auricular es una entidad frecuente en pacientes con Enfermedad Cerebrovascular; aproximadamente 1 de cada 8 personas con Enfermedad Cerebrovascular tiene Fibrilación Auricular, siendo la edad media de estos pacientes mayor. No es infrecuente encontrar pacientes con evento cardioembólico y otras comorbilidades.


Objective: To determine the prevalence of Atrial Fibrillation in hospitalized patients with the diagnosis of Cerebrovascular Disease. Material and methods: A descriptive cross-sectional study was made. The clinical charts of hospitalized patients with the diagnosis of Cerebrovascular Disease from February to June 2006 in ôHospital Nacional Cayetano Herediaõ and ôHospital Nacional Arzobispo Loayzaõ were reviewed. 136 cases were reviewed (29 from the Hospital Nacional Cayetano Heredia, and 107 from the Hospital Nacional Arzobispo Loayza). Results: Among the patients with Cerebrovascular Disease, 116 were ischemic (85.3 per cent) and 20 were hemorrhagic. 75 were females (55.1 per cent). The prevalence of Atrial Fibrillation found was 13.2 per cent. The mean age of the Atrial Fibrillation group (79.72 ± 7.09) was higher than those without it (65.75 ± 14.73) (p< 0.01). Left atrium`s enlargement was the most frequent finding in the Atrial Fibrillation group (92.3 per cent) (p<0.01). Conclusions: Atrial Fibrillation is a frequent entity in patients with Cerebrovascular Disease, approximately 1 of every 8 patients with stroke hasAtrial Fibrillation. The mean age of patients with Atrial Fibrillation is higher than those without it. Patients whohad suffered a cardioembolic event also have various comorbidities associated.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano de 80 o más Años , Accidente Cerebrovascular , Fibrilación Atrial , Prevalencia , Epidemiología Descriptiva , Estudios Transversales , Hospitales Provinciales
8.
Clin Exp Allergy ; 37(3): 391-9, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17359389

RESUMEN

BACKGROUND: When the clinical history is not conclusive, it may be difficult to make an accurate interpretation of the value of skin tests and serum-specific IgE to cat allergens in asthma cases. OBJECTIVE: To analyse the diagnostic efficiency of skin testing (ST) and serum-specific IgE to cat allergens, based on the results of bronchial-specific challenge with cat epithelium. METHODS: Sixty-four asthma patients (49 with cat exposure and 15 without) who did not clearly relate their asthma symptoms to cat exposure and had a positive skin prick testing and/or a positive cat dander-specific IgE determination (CAP-system) underwent intradermal skin tests and specific bronchial challenge with cat epithelium. The results were analysed by receiver operating characteristics curves (ROC curves) and logistic regression. Sensitivity, specificity, positive predictive values and negative predictive values were calculated for different cut-off points. RESULTS: Twenty-seven patients (42.2%) had a positive bronchial-specific challenge. The area under the ROC curve for serum-specific IgE quantification is 0.85, which makes a good diagnostic tool out of this test. Intradermal ST predicts the outcome of the bronchoprovocation test better than skin prick testing (area under the ROC curve of 0.74 vs. area under the ROC curve of 0.54, respectively). The logistic regression analysis shows that the estimated probability of a positive bronchial challenge is > or =93% if CAP values are > or =17 kU(A)/L, whereas if CAP values are less than 0.35 kU(A)/L the estimated probability of a positive bronchial challenge is 16%. When the intradermal skin test is negative, the estimated probability of a positive bronchoprovocation test is 9%, being the test that better identifies patients with a negative bronchoprovocation test. CONCLUSIONS: Levels of serum-specific IgE to cat allergens and intradermal ST can be used to diagnose and treat more accurately asthmatic patients sensitized to cat epithelium when there is uncertainty about cat epithelium causality.


Asunto(s)
Alérgenos/análisis , Gatos , Hipersensibilidad/inmunología , Inmunoglobulina E/análisis , Hipersensibilidad Respiratoria/inmunología , Adolescente , Adulto , Alérgenos/inmunología , Animales , Pruebas de Provocación Bronquial/métodos , Femenino , Humanos , Hipersensibilidad/diagnóstico , Masculino , Persona de Mediana Edad , Hipersensibilidad Respiratoria/diagnóstico , Pruebas Cutáneas/métodos
9.
Clin. transl. oncol. (Print) ; 8(9): 692-693, sept. 2006. ilus
Artículo en Inglés | IBECS | ID: ibc-124750

RESUMEN

Cutaneous metastasis from thyroid carcinoma is infrequent. Leukemia as a second malignancy after treatment of thyroid cancer is also rare. We present a patient with a relapsed thyroid carcinoma treated with thyroid ablation with I 131 and loco-regional radiotherapy, who consulted by global worsening, weight lost, and multiple cutaneous nodes. Our patient is unusual in that she showed multisystem involvement at the time of hospital admission, and the specific skin lesions were the first sign of her acute monocytic leukemia (AU)


Asunto(s)
Humanos , Femenino , Anciano , Carcinoma Papilar/radioterapia , Leucemia Monocítica Aguda/diagnóstico , Leucemia Inducida por Radiación/diagnóstico , Neoplasias Primarias Secundarias/diagnóstico , Neoplasias Cutáneas/diagnóstico , Neoplasias de la Tiroides/radioterapia
10.
Virologie (Montrouge) ; 9(4): 315-325, 2005 Aug 01.
Artículo en Francés | MEDLINE | ID: mdl-34679297

RESUMEN

Heparan sulphates are complex polysaccharides that belong to a class of molecules called glycosaminoglycans. Linked to different core proteins, they are ubiquitously expressed at most cells' surface. These molecules interact with a huge number of distinct proteins and regulate their biological activities. In particular different viruses make use of heparan sulphate interactive properties to dock themselves at the surface of their cellular targets. This interaction enables the viruses to concentrate at the close proximity of others molecules that act as co-receptors, and as such increases viral entry. Recent progresses in the structural characterisation of glycosaminoglycans have helped to understand the relationship between the structure of these molecules and their ability to recognise viral capside or envelope glycoproteins. These works also showed the direct role of these molecules in viral tropism and mechanism of entry, and suggest medical applications as biotechnological strategies.

11.
J Wound Care ; 13(6): 221-5, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15214139

RESUMEN

OBJECTIVE: To evaluate the efficacy, tolerance and acceptability of a lipidocolloid dressing, Urgotul (Laboratoires Urgo), in the local treatment of acute and chronic paediatric wounds. METHOD: Two non-comparative multicentre prospective clinical studies were conducted using the same protocol in France and Germany. A total of 100 patients were recruited from 16 centres (11 in France and five in Germany), and followed up for four weeks. Seventy wounds (55 burns and 15 other wounds) from France and 30 from Germany (22 burns and eight other wounds) were evaluated by nursing staff at every dressing change and by the medical investigator on a weekly basis. RESULTS: In the French study population, 86% of the burns (superficial and deep partial-thickness) and 53% of the other wounds healed completely within the four weeks. Figures for the German study population were 100% and 88% respectively. Pain was evaluated using pain scales adapted to the patient's age (objective pain scale, faces scale for pain and a visual analogue scale) at each dressing change. Dressing removal was non-traumatic, inducing very limited pain. Minor local adverse events were reported in four children. CONCLUSION: Urgotul is not only efficacious, but also well-tolerated and accepted by children with acute and chronic wounds. The dressing, therefore, might be an appropriate and highly promising alternative to conventional dressings.


Asunto(s)
Quemaduras/terapia , Coloides/uso terapéutico , Apósitos Oclusivos , Vaselina/uso terapéutico , Heridas y Lesiones/terapia , Vendas Hidrocoloidales , Quemaduras/patología , Niño , Preescolar , Femenino , Francia , Alemania , Humanos , Lactante , Masculino , Dolor/prevención & control , Estudios Prospectivos , Cicatrización de Heridas , Heridas y Lesiones/patología
14.
Allergy ; 57(10): 946-9, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12269944

RESUMEN

BACKGROUND: Prescribing therapeutic elimination diets in patients with fruit allergy should include recommendations on which other foods of the same family or group may be safely consumed. Evidence-based data on the management of fruit allergy are lacking; therefore, advice may vary from just avoiding the offending fruit, to overly restrictive diets of the entire botanical family. The aims of this investigation were to assess clinical reactivity to potential cross-reactive foods in fruit-allergic patients, and the implications for prescribing specific therapeutic elimination diets. METHODS: Sixty-five adults diagnosed with clinical allergy to one or more fruits were evaluated for IgE-mediated allergy to other related foods, which might share cross-reactive antigens. Those with actual allergy to some Rosaceae fruit (including peach, apple, apricot, plum, and almond) underwent skin prick testing (SPT), food-specific IgE assessment by the Pharmacia CAP-FEIA system, and oral challenges with the entire group. For those with allergy to other fruits (chestnut, melon, banana, kiwi, or avocado) immunologic and clinical reactivity to all five were evaluated. Since a number of people in the study also had proven clinically allergy to some nut or legume (peanut, sunflower seed, walnut, pistachio, or hazelnut), the reactivity to the entire set was investigated. RESULTS: Thirty-four of those tested (52%) were found to be clinically allergic to more than one fruit, so 125 allergic reactions occurred in the 65 patients. Peach, melon, kiwi, apple, and banana accounted for 72% of allergic reactions. Forty-two (65%) had sensitization to pollens, causing seasonal allergic rhinitis and/or asthma, and 18 (28%) were sensitized to latex. The 65 with IgE-mediated fruit allergy underwent 351 additional SPT and food-specific IgE determinations with potential cross-reactive foods considered in this study; 223 (64%) of these results were positive. The routine challenges with potential cross-reactive foods uncovered 18 further reactions in 14 (22%) out of 65 (to avocado in seven; apricot in three; plum in one; almond and peanut in one; banana and hazelnut in one; avocado, banana and kiwi in one). Only 8% (18/223) of positive results for SPT, or food-specific IgE levels of greater than 0.35 kU(A)/l to potential cross-reactive foods investigated in this study, were clinically relevant. CONCLUSION: Elimination diets that rely on total group avoidance, or only on the results of allergy testing, might have resulted in unnecessary restriction of 205 foods in the 65 people studied. The lack of routine oral challenges with related fruits--before prescribing dietary restriction--may have allowed 18 food reactions in one-fifth (14/65) of patients to be overlooked.


Asunto(s)
Reacciones Cruzadas/inmunología , Hipersensibilidad a los Alimentos/inmunología , Frutas/efectos adversos , Frutas/inmunología , Adolescente , Adulto , Anciano , Especificidad de Anticuerpos/inmunología , Ensayos Clínicos Controlados como Asunto , Método Doble Ciego , Medicina Basada en la Evidencia , Femenino , Humanos , Inmunoglobulina E/inmunología , Inmunoglobulina E/metabolismo , Masculino , Persona de Mediana Edad , Pruebas Cutáneas , España
15.
An. sist. sanit. Navar ; 25(supl.2): 45-61, mayo 2002. tab
Artículo en Es | IBECS | ID: ibc-20179

RESUMEN

La dermatitis atópica es la dermatosis más frecuente entre los niños menores de 11 años. Es una enfermedad cutánea inflamatoria, crónica y recurrente, cursa con múltiples brotes y reagudizaciones que afectan al niño, y por consiguiente a su entorno familiar, generalmente durante años. Su carácter crónico y la falta de terapéuticas totalmente satisfactorias obligan al pediatra de atención primaria a considerar a esta entidad como factor condicionante de la calidad de vida de los pacientes y como signo de atención ante el posible desarrollo de otros procesos alérgicos. Al no disponer de un tratamiento curativo, adquieren especial relevancia la colaboración familiar, las medidas de prevención de las reagudizaciones y la eficacia en el tratamiento sintomático de las mismas (AU)


Asunto(s)
Niño , Humanos , Dermatitis Atópica/diagnóstico , Atención Primaria de Salud , Calidad de Vida , Antialérgicos/uso terapéutico , Dermatitis Atópica/prevención & control , Dermatitis Atópica/etiología , Dermatitis Atópica/tratamiento farmacológico
16.
An Sist Sanit Navar ; 25 Suppl 2: 45-61, 2002.
Artículo en Español | MEDLINE | ID: mdl-12861257

RESUMEN

Atopic dermatitis is the most frequent dermatitis amongst children under 11 years of age. It is an inflammatory cutaneous disease, chronic and recurrent, and it involves numerous outbreaks and relapses that affect the child, and hence his family milieu, generally for several years. Its chronic character and the lack of fully satisfactory therapies force the primary care paediatrician to consider this entity as a factor conditioning the quality of life of the patients and as a warning sign for the possible development of other allergic processes. As we do not have a curative treatment available, special relevance is assumed by family collaboration, by the measures for preventing relapses and by efficacy in their symptomatic treatment.

17.
J Allergy Clin Immunol ; 108(2): 295-7, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11496250

RESUMEN

The ingestion of lupine seed flour (LSF) has been reported as a cause of allergic reactions, particularly in patients sensitized to peanut, but there is little evidence of its allergenic potential after inhalation. We sought to evaluate the clinical and immunologic reactivity to lupine in employees working with this seed flour. An occupational history was obtained in 7 subjects (median age, 35 years) working with LSF at an agricultural research center. Three subjects (1, 6, and 7) reported work-related allergy symptoms immediately after being exposed to lupine. Skin prick test results with LSF extract were positive in these 3 patients with work-related symptoms. Moreover, lupine-specific IgE antibodies were detected in subjects 6 and 7. In subject 6, the controlled exposure to LSF elicited immediate naso-ocular symptoms without changes in FEV(1). In subject 7, a bronchial provocation with LSF extract elicited an immediate fall (25%) in FEV(1). Double-blinded, placebo-controlled LSF oral challenge results were positive in subjects 6 and 7. Immunologic reactivity to other legumes was detected in subjects 6 and 7, but specific inhalation testing and oral challenge results were negative. Thus, the inhalation of lupine flour could be an important cause of allergic sensitization in exposed workers and might give rise to occupational asthma and food allergy.


Asunto(s)
Fabaceae/inmunología , Hipersensibilidad Inmediata/etiología , Hipersensibilidad/etiología , Inmunoglobulina E , Personal de Laboratorio Clínico , Enfermedades Profesionales/etiología , Plantas Medicinales , Adulto , Productos Agrícolas/inmunología , Método Doble Ciego , Femenino , Humanos , Hipersensibilidad/inmunología , Hipersensibilidad Inmediata/inmunología , Persona de Mediana Edad , Enfermedades Profesionales/inmunología , Exposición Profesional , Semillas/inmunología
18.
Biochem J ; 354(Pt 1): 141-7, 2001 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-11171089

RESUMEN

Heparan sulphates are highly sulphated linear polysaccharides involved in many cellular functions. Their biological properties stem from their ability to interact with a wide range of proteins. An increasing number of studies, using heparan sulphate-derived oligosaccharides, suggest that specific structural features within the polysaccharide are responsible for ligand recognition and regulation. In the present study, we show that strong anion-exchange HPLC alone, a commonly used technique for purification of heparan sulphate-derived oligosaccharides, may not permit the isolation of highly pure heparan sulphate oligosaccharide species. This was determined by PAGE analysis of hexa-, octa- and decasaccharide samples deemed to be pure by strong anion-exchange HPLC. In addition, subtle differences in the positioning of sulphate groups within heparan sulphate hexasaccharides were impossible to detect by strong anion-exchange HPLC. PAGE analysis on the other hand afforded excellent resolution of these structural isomers. The precise positioning of specific sulphate groups has been implicated in determining the specificity of heparan sulphate interactions and biological activities; hence, the purification of oligosaccharide species that differ in this way becomes an important issue. In this study, we have used strong anion-exchange HPLC and PAGE techniques to allow production of the homogeneous heparan sulphate oligosaccharide species that will be required for the detailed study of structure/activity relationships.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Cromatografía por Intercambio Iónico/métodos , Electroforesis en Gel de Poliacrilamida/métodos , Heparitina Sulfato/aislamiento & purificación , Animales , Heparitina Sulfato/química , Porcinos
19.
Glycobiology ; 10(11): 1183-92, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11087710

RESUMEN

The interaction of heparan sulfate (HS) (and the closely related molecule heparin) with FGF-1 is a requirement for enabling the growth factor to activate its cell surface tyrosine kinase receptor. However, little is known about the regulatory role of naturally occurring cell surface HS in FGF-1 activation. We have addressed this issue by utilizing a library of HS oligosaccharides, which are defined in both length and sulfate content. Mitogenic activation assays using these oligosaccharides showed that HS contained both FGF-1 activatory and inhibitory sugar sequences. Further analysis of these oligosaccharides showed a clear correlation between FGF-1 promoting activity and their 6-O-sulfate content. The results, in particular with the dodecasaccharide sequences, suggested that specific positioning of 6-O-sulfate groups may be required for the promotion of FGF-1 mitogenic activity. This may also be true for 2-O-sulfate groups though the evidence was not as conclusive. Differential activation of FGF-1 and FGF-2 was also observed and found to be mediated by both oligosaccharide length and sulfation pattern, with different specific O-sulfate positioning being implicated for the promotion of different growth factors. These results suggest that variation and tight control of the fine structure of HS may allow cells to not only control their positive/negative responses to individual FGFs but also to change specificity towards promotion of different members of the FGF family.


Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/farmacología , Factores de Crecimiento de Fibroblastos/farmacología , Heparitina Sulfato/química , Heparitina Sulfato/farmacología , Mitógenos/farmacología , Oligosacáridos/química , Oligosacáridos/farmacología , Animales , Secuencia de Carbohidratos , División Celular/efectos de los fármacos , Línea Celular , Factor 1 de Crecimiento de Fibroblastos , Ratones , Datos de Secuencia Molecular , Relación Estructura-Actividad
20.
J Allergy Clin Immunol ; 106(5): 968-72, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11080722

RESUMEN

BACKGROUND: Few studies have evaluated IgE-mediated hypersensitivity to melon with details of clinical reactions confirmed by double-blind, placebo-controlled, food challenges (DBPCFCs). OBJECTIVE: We sought to investigate clinical features (type and severity of reactions, age at onset, results of skin prick and in vitro tests, and incidence of other allergic diseases and associated food allergies) of acute allergic reactions to melon confirmed by DBPCFCs. METHODS: Fifty-three consecutive adult patients complaining of adverse reactions to melon were included in the study. Skin prick tests and detection of specific IgE were performed in all patients with melon, avocado, kiwi, banana, chestnut, latex, pollen, and other offending foods. Patients first underwent an open food challenge, unless they had a convincing history of severe anaphylaxis. Positive open food challenge reactions were subsequently evaluated by DBPCFCs. RESULTS: Actual clinical reactivity was confirmed in 19 (36%) of 53 patients. The most frequent symptom was oral allergy syndrome (n = 14), but two patients experienced life-threatening reactions, including respiratory symptoms and hypotension. The positive predictive value for a skin prick test was 42%, and that for specific IgE measurement was 44%. Forty-five reactions to 15 other foods were confirmed in 18 patients. The most common foods associated with melon allergy were avocado (n = 7), banana (n = 7), kiwi (n = 6), watermelon (n = 6), and peach (n = 5). Onset of melon-induced allergic symptoms occurred from 6 to 45 years (median, 20 years), preceded by seasonal rhinitis, asthma, or both in 88% (15/17). CONCLUSION: About one third of reported reactions to melon are confirmed by means of DBPCFC, which has been proven to be the most reliable procedure in the diagnosis of clinical fruit allergy. Isolated melon allergy is rare, with most patients either having allergic rhinitis, asthma, or both and associated food allergies.


Asunto(s)
Hipersensibilidad a los Alimentos/etiología , Frutas/efectos adversos , Adolescente , Adulto , Edad de Inicio , Estudios Cruzados , Método Doble Ciego , Hipersensibilidad a los Alimentos/inmunología , Hipersensibilidad a los Alimentos/fisiopatología , Frutas/inmunología , Humanos , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...